Efficacy and safety of nalfurafine hydrochloride for pruritus in patients with chronic liver disease in Japan

被引:0
|
作者
Kawano, Tadamichi [1 ]
Atsukawa, Masanori [1 ]
Tsubota, Akihito [2 ]
Shioda, Kaori [1 ]
Ono, Hiroki [1 ]
Okubo, Tomomi [1 ]
Arai, Taeang [1 ]
Hayama, Korenobu [1 ]
Kaneko, Keiko [1 ]
Itokawa, Norio [1 ]
Iwakiri, Katsuhiko [1 ]
机构
[1] Nippon Med Sch, Div Gastroenterol & Hepatol, Tokyo, Japan
[2] Jikei Univ, Core Res Facil, Sch Med, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
WED-327
引用
收藏
页码:S240 / S241
页数:2
相关论文
共 50 条
  • [31] RELIEF OF PRURITUS BY CHOLESTYRAMINE IN CHRONIC LIVER DISEASE
    OSTER, ZH
    RACHMILE.EA
    MORAN, E
    STEIN, Y
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1965, 1 (4P1): : 599 - +
  • [32] Pruritus in chronic liver disease: Mechanisms and treatment
    Bergasa N.V.
    Current Gastroenterology Reports, 2004, 6 (1) : 10 - 16
  • [33] Efficacy and safety of pregabalin versus gabapentin among chronic pruritus patients: a randomized study
    Saravanan, Aswini
    Anil, Abhishek
    Bhardwaj, Abhishek
    Shukla, Ravindra
    Bajpai, Nitin Kumar
    Singh, Surjit
    Ambwani, Sneha
    Lahoria, Utkrist
    Shamim, Muhammad Aaqib
    Dwivedi, Pradeep
    Varthya, Shoban Babu
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
  • [34] Comparison of Safety and Efficacy of Pregabalin versus Gabapentin for the treatment of Uremic Pruritus in Patients with Chronic Kidney Disease on Maintenance Haemodialysis
    Ravindran, Ashima
    Kunnath, Rajesh Peringanazhi
    Sunny, Anjali
    Vimal, Binoo
    INDIAN JOURNAL OF PALLIATIVE CARE, 2020, 26 (03) : 281 - 286
  • [35] Zinc deficiency in patients with chronic liver disease in Japan
    Ozeki, Itaru
    Arakawa, Tomohiro
    Suii, Hirokazu
    Tatsumi, Ryoji
    Yamaguchi, Masakatsu
    Nakajima, Tomoaki
    Kuwata, Yasuaki
    Toyota, Joji
    HEPATOLOGY RESEARCH, 2020, 50 (03) : 396 - 401
  • [36] SAFETY AND EFFICACY OF TESTOSTERONE SUPPLEMENTATION IN MEN WITH CHRONIC LIVER DISEASE
    Boxer, Andrew
    Small, Katherine
    Tamler, Ronald
    Dieterich, Douglas T.
    HEPATOLOGY, 2010, 52 (04) : 462A - 463A
  • [37] Safety and Efficacy of Continuous Use Avatrombopag in Chronic Liver Disease
    Mazzoni, Sandra
    Angelini, Dana E.
    BLOOD, 2022, 140 : 11236 - 11237
  • [38] Safety and efficacy of hepatitis A vaccine in children with chronic liver disease
    El-Karaksy, Hanaa Mostafa
    El-Hawary, Manal Ismail
    El-Koofy, Nehal Mohammad
    El-Sayed, Rokaya
    El-Raziky, Mona Al-Saeed
    Mansour, Samah Asaad
    Taha, Gamal Mohammad
    El-Mougy, Fatma
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (45) : 7337 - 7340
  • [39] Response of patients with hemodialysis-associated pruritus to new treatment algorithm with nalfurafine hydrochloride: A retrospective survey-based study
    Takahashi N.
    Yoshizawa T.
    Kumagai J.
    Kawanishi H.
    Moriishi M.
    Masaki T.
    Tsuchiya S.
    Renal Replacement Therapy, 2 (1)
  • [40] Factors Related to Sleeping Disorder Due to Pruritus in Patients with Chronic Liver Disease
    Hiraoka, Atsushi
    Onishi, Miho
    Koyama, Satsuki
    Kato, Masaya
    Marui, Kaori
    Murakami, Taisei
    Onishi, Kei
    Adachi, Tomoko
    Matsuoka, Junko
    Ueki, Hidetaro
    Yoshino, Takeaki
    Tsuruta, Miho
    Aibiki, Toshihiko
    Okudaira, Tomonari
    Kuroda, Taira
    Iwasaki, Ryuichiro
    Suga, Yoshifumi
    Miyata, Hideki
    Ninomiya, Tomoyuki
    Hirooka, Masashi
    Abe, Masanori
    Matsuura, Bunzo
    Michitaka, Kojiro
    Hiasa, Yoichi
    INTERNAL MEDICINE, 2021, 60 (20) : 3195 - 3203